JP2002536300A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002536300A5 JP2002536300A5 JP2000596019A JP2000596019A JP2002536300A5 JP 2002536300 A5 JP2002536300 A5 JP 2002536300A5 JP 2000596019 A JP2000596019 A JP 2000596019A JP 2000596019 A JP2000596019 A JP 2000596019A JP 2002536300 A5 JP2002536300 A5 JP 2002536300A5
- Authority
- JP
- Japan
- Prior art keywords
- composition object
- compound
- alkyl
- inflammatory response
- amino
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 description 31
- -1 hydroxy, amino Chemical group 0.000 description 19
- 230000028709 inflammatory response Effects 0.000 description 13
- 150000001875 compounds Chemical class 0.000 description 7
- 125000000217 alkyl group Chemical group 0.000 description 5
- 125000000753 cycloalkyl group Chemical group 0.000 description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 125000006260 ethylaminocarbonyl group Chemical group [H]N(C(*)=O)C([H])([H])C([H])([H])[H] 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 125000006619 (C1-C6) dialkylamino group Chemical group 0.000 description 3
- 229940099471 Phosphodiesterase inhibitor Drugs 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 239000002571 phosphodiesterase inhibitor Substances 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- KXKVLQRXCPHEJC-UHFFFAOYSA-N acetic acid trimethyl ester Natural products COC(C)=O KXKVLQRXCPHEJC-UHFFFAOYSA-N 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-M cyclohexanecarboxylate Chemical compound [O-]C(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-M 0.000 description 2
- NZNMSOFKMUBTKW-UHFFFAOYSA-N cyclohexanecarboxylic acid Chemical compound OC(=O)C1CCCCC1 NZNMSOFKMUBTKW-UHFFFAOYSA-N 0.000 description 2
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 208000028867 ischemia Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- HJORMJIFDVBMOB-UHFFFAOYSA-N rolipram Chemical group COC1=CC=C(C2CC(=O)NC2)C=C1OC1CCCC1 HJORMJIFDVBMOB-UHFFFAOYSA-N 0.000 description 2
- 229950005741 rolipram Drugs 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 description 1
- 102000009346 Adenosine receptors Human genes 0.000 description 1
- 108050000203 Adenosine receptors Proteins 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 230000008484 agonism Effects 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 125000005418 aryl aryl group Chemical group 0.000 description 1
- VZFUCHSFHOYXIS-UHFFFAOYSA-N cycloheptane carboxylic acid Natural products OC(=O)C1CCCCCC1 VZFUCHSFHOYXIS-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- FPIQZBQZKBKLEI-UHFFFAOYSA-N ethyl 1-[[2-chloroethyl(nitroso)carbamoyl]amino]cyclohexane-1-carboxylate Chemical compound ClCCN(N=O)C(=O)NC1(C(=O)OCC)CCCCC1 FPIQZBQZKBKLEI-UHFFFAOYSA-N 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 238000002650 immunosuppressive therapy Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 208000020431 spinal cord injury Diseases 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009529 traumatic brain injury Effects 0.000 description 1
Applications Claiming Priority (13)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11802999P | 1999-02-01 | 1999-02-01 | |
| US60/118,029 | 1999-02-01 | ||
| US12431699P | 1999-03-12 | 1999-03-12 | |
| US60/124,316 | 1999-03-12 | ||
| US13337499P | 1999-05-10 | 1999-05-10 | |
| US60/133,374 | 1999-05-10 | ||
| US13557399P | 1999-05-24 | 1999-05-24 | |
| US60/135,573 | 1999-05-24 | ||
| US09/333,387 | 1999-06-15 | ||
| US09/333,387 US6232297B1 (en) | 1999-02-01 | 1999-06-15 | Methods and compositions for treating inflammatory response |
| US15141299P | 1999-08-30 | 1999-08-30 | |
| US60/151,412 | 1999-08-30 | ||
| PCT/US2000/002324 WO2000044763A2 (en) | 1999-02-01 | 2000-01-31 | Compositions for treating inflammatory response |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002536300A JP2002536300A (ja) | 2002-10-29 |
| JP2002536300A5 true JP2002536300A5 (https=) | 2010-12-24 |
| JP4837831B2 JP4837831B2 (ja) | 2011-12-14 |
Family
ID=27557920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000596019A Expired - Fee Related JP4837831B2 (ja) | 1999-02-01 | 2000-01-31 | 炎症反応を治療するための組成物 |
Country Status (25)
| Country | Link |
|---|---|
| EP (1) | EP1150991B1 (https=) |
| JP (1) | JP4837831B2 (https=) |
| KR (1) | KR100668006B1 (https=) |
| CN (1) | CN1191266C (https=) |
| AR (1) | AR029332A1 (https=) |
| AT (1) | ATE263777T1 (https=) |
| AU (2) | AU778870B2 (https=) |
| BR (1) | BR0007864A (https=) |
| CA (1) | CA2361614C (https=) |
| CZ (1) | CZ296404B6 (https=) |
| DE (1) | DE60009665T2 (https=) |
| DK (1) | DK1150991T3 (https=) |
| EE (1) | EE05185B1 (https=) |
| ES (1) | ES2215609T3 (https=) |
| HU (1) | HU228937B1 (https=) |
| IL (2) | IL144188A0 (https=) |
| MX (1) | MXPA01007850A (https=) |
| MY (1) | MY129445A (https=) |
| NO (1) | NO321216B1 (https=) |
| NZ (1) | NZ513096A (https=) |
| PL (1) | PL199953B1 (https=) |
| PT (1) | PT1150991E (https=) |
| SK (1) | SK284877B6 (https=) |
| UA (1) | UA72912C2 (https=) |
| WO (1) | WO2000044763A2 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6448235B1 (en) | 1994-07-11 | 2002-09-10 | University Of Virginia Patent Foundation | Method for treating restenosis with A2A adenosine receptor agonists |
| US6514949B1 (en) | 1994-07-11 | 2003-02-04 | University Of Virginia Patent Foundation | Method compositions for treating the inflammatory response |
| US7427606B2 (en) | 1999-02-01 | 2008-09-23 | University Of Virginia Patent Foundation | Method to reduce inflammatory response in transplanted tissue |
| US6232297B1 (en) | 1999-02-01 | 2001-05-15 | University Of Virginia Patent Foundation | Methods and compositions for treating inflammatory response |
| US7378400B2 (en) | 1999-02-01 | 2008-05-27 | University Of Virginia Patent Foundation | Method to reduce an inflammatory response from arthritis |
| US6322771B1 (en) | 1999-06-18 | 2001-11-27 | University Of Virginia Patent Foundation | Induction of pharmacological stress with adenosine receptor agonists |
| IL133680A0 (en) | 1999-09-10 | 2001-04-30 | Can Fite Technologies Ltd | Pharmaceutical compositions comprising an adenosine receptor agonist or antagonist |
| NZ556354A (en) | 2001-10-01 | 2008-10-31 | Univ Virginia | 2-Propynyl adenosine analogs having A2A agonist activity and compositions thereof |
| US20050033044A1 (en) | 2003-05-19 | 2005-02-10 | Bristol-Myers Squibb Pharma Company | Methods for preparing 2-alkynyladenosine derivatives |
| AU2005231440B9 (en) * | 2004-04-02 | 2012-02-23 | Dogwood Pharmaceuticals, Inc. | Selective antagonists of A2A adenosine receptors |
| US7396825B2 (en) * | 2004-05-03 | 2008-07-08 | University Of Virginia Patent Foundation | Agonists of A2A adenosine receptors for treatment of diabetic nephropathy |
| WO2006023272A1 (en) | 2004-08-02 | 2006-03-02 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having a2a agonist activity |
| US7576069B2 (en) | 2004-08-02 | 2009-08-18 | University Of Virginia Patent Foundation | 2-polycyclic propynyl adenosine analogs having A2A agonist activity |
| AU2005267706B2 (en) | 2004-08-02 | 2011-12-08 | University Of Virginia Patent Foundation | 2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity |
| US8178509B2 (en) | 2006-02-10 | 2012-05-15 | University Of Virginia Patent Foundation | Method to treat sickle cell disease |
| EP2021350B1 (en) | 2006-03-21 | 2016-12-21 | Rheinische Friedrich-Wilhelms-Universität Bonn | Phosphorylated a2a receptor agonists |
| US8188063B2 (en) | 2006-06-19 | 2012-05-29 | University Of Virginia Patent Foundation | Use of adenosine A2A modulators to treat spinal cord injury |
| AU2007263728A1 (en) * | 2006-06-27 | 2008-01-03 | Biovitrum Ab (Publ) | Adenosine derivatives for the treatment of pain |
| US8058259B2 (en) | 2007-12-20 | 2011-11-15 | University Of Virginia Patent Foundation | Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists |
| KR20110028531A (ko) * | 2008-07-03 | 2011-03-18 | 유니버시티 오브 버지니아 페이턴트 파운데이션 | 아파데노손의 단위 용량 |
| BRPI1014224A2 (pt) | 2009-06-30 | 2019-09-24 | Forest Laboratories Holdings Ltd | composto, composição farmacêutica,e, método para tratar um estado. |
| FR2960876B1 (fr) | 2010-06-03 | 2012-07-27 | Sanofi Aventis | Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique. |
| CN114096552B (zh) * | 2019-06-21 | 2024-09-27 | 中国人民解放军军事科学院军事医学研究院 | 具有a2a腺苷受体拮抗作用的小分子化合物 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3537228A1 (de) * | 1985-10-19 | 1987-04-23 | Huels Chemische Werke Ag | Verfahren zur herstellung von cyclohexylverbindungen |
| JPS6299330A (ja) * | 1985-10-25 | 1987-05-08 | Yamasa Shoyu Co Ltd | 抗高血圧剤 |
| EP0444196B1 (en) * | 1988-11-15 | 1994-06-08 | Yamasa Shoyu Kabushiki Kaisha | Agent for treatment and prophylaxis of ischemic disease of heart or brain |
| ES2077070T3 (es) * | 1989-06-20 | 1995-11-16 | Yamasa Shoyu Kk | Intermedio de sintesis de 2-alquiniladenosina, produccion de dicho intermedio, produccion de 2-alquiniladenosina a partir de dicho intermedio, y derivado de 2-alquiniladenosina estable. |
| WO1991009864A1 (fr) * | 1990-01-04 | 1991-07-11 | Yamasa Shoyu Kabushiki Kaisha | Medicament pour le traitement d'affections ischemiques du c×ur ou du cerveau |
| JPH03287537A (ja) * | 1990-03-31 | 1991-12-18 | Yamasa Shoyu Co Ltd | 抗動脈硬化症剤 |
| JP3025559B2 (ja) * | 1990-07-19 | 2000-03-27 | ヤマサ醤油株式会社 | アデノシン誘導体 |
| JP3025557B2 (ja) * | 1991-06-28 | 2000-03-27 | ヤマサ醤油株式会社 | ２‐アルキニルアデノシン誘導体 |
| JP3053908B2 (ja) * | 1991-06-28 | 2000-06-19 | ヤマサ醤油株式会社 | ２‐アルキニルアデノシン誘導体 |
| IT1254915B (it) * | 1992-04-24 | 1995-10-11 | Gloria Cristalli | Derivati di adenosina ad attivita' a2 agonista |
| AU7449598A (en) * | 1997-05-23 | 1998-12-11 | Nippon Shinyaku Co. Ltd. | Medicinal composition for prevention or treatment of hepatopathy |
| AU740770B2 (en) * | 1997-06-18 | 2001-11-15 | Aderis Pharmaceuticals, Inc. | Compositions and methods for preventing restenosis following revascularization procedures |
| JPH11335302A (ja) * | 1998-05-26 | 1999-12-07 | Toa Eiyo Ltd | 安定な医薬組成物 |
| JP3619017B2 (ja) * | 1998-06-24 | 2005-02-09 | 日本臓器製薬株式会社 | 新規アラビノシルアデニン誘導体 |
| JP2002173427A (ja) * | 1998-09-01 | 2002-06-21 | Yamasa Shoyu Co Ltd | 眼疾患治療用医薬組成物 |
-
2000
- 2000-01-31 UA UA2001086055A patent/UA72912C2/uk unknown
- 2000-01-31 ES ES00905833T patent/ES2215609T3/es not_active Expired - Lifetime
- 2000-01-31 DE DE60009665T patent/DE60009665T2/de not_active Expired - Lifetime
- 2000-01-31 MX MXPA01007850A patent/MXPA01007850A/es active IP Right Grant
- 2000-01-31 PT PT00905833T patent/PT1150991E/pt unknown
- 2000-01-31 IL IL14418800A patent/IL144188A0/xx unknown
- 2000-01-31 BR BR0007864-6A patent/BR0007864A/pt not_active Application Discontinuation
- 2000-01-31 DK DK00905833T patent/DK1150991T3/da active
- 2000-01-31 JP JP2000596019A patent/JP4837831B2/ja not_active Expired - Fee Related
- 2000-01-31 HU HU0200224A patent/HU228937B1/hu not_active IP Right Cessation
- 2000-01-31 KR KR1020017009640A patent/KR100668006B1/ko not_active Expired - Fee Related
- 2000-01-31 NZ NZ513096A patent/NZ513096A/xx not_active IP Right Cessation
- 2000-01-31 AU AU27454/00A patent/AU778870B2/en not_active Ceased
- 2000-01-31 MY MYPI20000343A patent/MY129445A/en unknown
- 2000-01-31 CN CNB008055092A patent/CN1191266C/zh not_active Expired - Fee Related
- 2000-01-31 CA CA002361614A patent/CA2361614C/en not_active Expired - Fee Related
- 2000-01-31 EE EEP200100397A patent/EE05185B1/xx not_active IP Right Cessation
- 2000-01-31 WO PCT/US2000/002324 patent/WO2000044763A2/en not_active Ceased
- 2000-01-31 EP EP00905833A patent/EP1150991B1/en not_active Expired - Lifetime
- 2000-01-31 AT AT00905833T patent/ATE263777T1/de active
- 2000-01-31 PL PL349644A patent/PL199953B1/pl unknown
- 2000-01-31 CZ CZ20012781A patent/CZ296404B6/cs not_active IP Right Cessation
- 2000-01-31 SK SK1097-2001A patent/SK284877B6/sk not_active IP Right Cessation
- 2000-02-01 AR ARP000100433A patent/AR029332A1/es not_active Application Discontinuation
-
2001
- 2001-07-05 IL IL144188A patent/IL144188A/en not_active IP Right Cessation
- 2001-07-13 NO NO20013507A patent/NO321216B1/no not_active IP Right Cessation
-
2005
- 2005-03-23 AU AU2005201255A patent/AU2005201255B2/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002536300A5 (https=) | ||
| EP1255764B1 (en) | Purine derivatives | |
| ES2909419T3 (es) | Métodos para el tratamiento de infecciones por coronaviridae | |
| JP5271913B2 (ja) | 化合物 | |
| EP0943616B1 (en) | Substituted imidazole derivatives and their use as cytokine inhibitors | |
| JP3167788B2 (ja) | 肝炎の処置に有用な１，３−オキサチオラン | |
| US20110229438A1 (en) | Method of inhibiting hepatitus c virus by combination of a 5,6-dihydro-1h-pyridin-2-one and one or more additional antiviral compounds | |
| KR101585848B1 (ko) | 관절염의 치료 방법 | |
| US20040082635A1 (en) | Fused cyclic compounds and medicinal use thereof | |
| JP2008505902A5 (https=) | ||
| EP0871622A1 (en) | Novel compounds | |
| JPH08259565A (ja) | 鏡像異性体ヒドロキシル化キサンチン化合物 | |
| CN1357002A (zh) | 治疗炎症应答的组合物 | |
| JPH05506436A (ja) | 冠状血管拡張剤および抗高血圧症剤としての２―アラルコキシおよび２―アルコキシアデノシン誘導体類 | |
| PL158050B1 (pl) | Sposób wytwarzania 5-podstawionych nukleozydów pirymidynowych PL PL | |
| JP2005519916A5 (https=) | ||
| EP2785707B1 (en) | Novel 2h-indazoles as ep2 receptor antagonists | |
| SK92898A3 (en) | Novel substituted imidazole compounds | |
| JP2009510075A (ja) | 抗ウイルス剤としての修飾４’−ヌクレオシド | |
| JP2001506239A (ja) | 新規化合物 | |
| JP2009501746A5 (https=) | ||
| JP2009542730A (ja) | 光学的に純粋なジヒドロピリミジン化合物類、及びウイルス性疾患の治療及び予防のための医薬調製のためのこれらの使用 | |
| CN108602842B (zh) | 杂环化合物及其制备方法和用途 | |
| RU2524573C2 (ru) | Способ получения (e)-n-(3-трет-бутил-5-(2,4-диоксо-3,4-дигидропиримидин-1(2н)-ил)-2-метокси-стирил)фенил)метансульфонамида и промежуточные соединения для его получения | |
| KR20220101697A (ko) | 페닐이속사졸릴 메틸렌-나프탈렌-에테르 유도체의 용도 및 약학적 조성물 |